Ramucirumab Benefit for US Patients With Gastric Cancer Mirrors Global Results
June 27th 2014
A geographic analysis of clinical trial results supporting the use of ramucirumab in advanced gastric cancer demonstrated that patients in the United States and other Western nations experienced similar survival gains and adverse events as did their counterparts in two other regions of the world.